Which Antibiotics Are Used for a Sinus Infection?

The short answer: antibiotics used for sinus infections

Most sinus infections are caused by viruses, and many resolve on their own without antibiotic treatment. Antibiotics do not help viral infections, so the first step in managing sinus symptoms is determining whether a bacterial cause is likely. When a clinician diagnoses acute bacterial rhinosinusitis, the Infectious Diseases Society of America (IDSA) guideline recommends amoxicillin-clavulanate as the preferred empiric antibiotic for both adults and children. This combination is chosen because it effectively targets the common bacteria responsible for these infections while minimizing the risk of treatment failure due to resistance.

For adults who cannot take amoxicillin-clavulanate, doxycycline is recognized as a valid alternative. Other common antibiotics are not suitable for routine use. The IDSA guideline does not recommend macrolides, such as azithromycin, or trimethoprim-sulfamethoxazole for empiric treatment of acute bacterial rhinosinusitis. This exclusion is based on high rates of resistance among respiratory pathogens, which makes these drugs unreliable for first-line therapy. Because antibiotic selection requires careful clinical judgment, patients should not assume that any available antibiotic is appropriate for their specific symptoms.

When a sinus infection may be bacterial

Symptoms of a sinus infection, such as nasal congestion, facial pressure, and discolored mucus, are common to both viral and bacterial illnesses. These symptoms alone do not justify automatically selecting an antibiotic. Clinicians rely on the duration and specific pattern of symptoms to distinguish between a typical viral upper-respiratory infection and likely acute bacterial rhinosinusitis.

The IDSA guideline identifies three clinical presentations that raise suspicion for a bacterial cause. The first is persistent compatible symptoms that last for at least 10 days without any improvement. The second is severe onset, characterized by a fever of at least 39°C (102°F) along with purulent nasal discharge or significant facial pain that lasts for at least 3 to 4 consecutive days. The third pattern is a “double worsening,” where symptoms initially improve after starting like a common cold, but then worsen again with new fever or nasal discharge.

Colored or thick mucus by itself should not be used as proof of a bacterial infection. Viral sinusitis frequently produces thick, yellow, or green mucus as the immune system responds to the virus. Color alone is not a reliable indicator for antibiotic use. The Centers for Disease Control and Prevention (CDC) advises medical evaluation when sinus symptoms last more than 10 days without improvement or worsen after initially improving. These patterns warrant assessment, but they do not independently confirm a bacterial cause without a clinician's full evaluation.

How clinicians choose an antibiotic

When antibiotic therapy is deemed necessary, the choice of medication is not based on a universal ranking of which drug is the strongest. Clinicians modify empiric choices according to several patient-specific factors. These include the patient's age, history of penicillin allergy, risk of resistant organisms, recent antibiotic use, disease severity, and the presence of comorbid or immunocompromising conditions.

For most adults and children with uncomplicated acute bacterial rhinosinusitis, amoxicillin-clavulanate remains the first-line choice. If a patient has a history of immediate-type penicillin allergy, or if other factors make the first-line drug unsuitable, clinicians consider alternatives. For adults, doxycycline is a recognized alternative. In cases of significant penicillin allergy, respiratory fluoroquinolones such as levofloxacin or moxifloxacin may also be listed as alternatives. These are clinician-selected options, not interchangeable self-treatment choices.

Pediatric considerations differ significantly from adult guidelines. Doxycycline and fluoroquinolones are generally not first-line choices for children due to age-related safety and development concerns, and their selection requires specific clinical judgment. Because local resistance patterns and individual health histories vary, an online drug list cannot determine the right prescription. Clinicians must assess the full clinical picture to ensure the selected antibiotic is both safe and likely to be effective for that specific patient.

Watchful waiting and what to expect after treatment starts

For some sinus infections, particularly those that do not present with severe features, a healthcare professional may recommend watchful waiting or delayed prescribing. This approach involves monitoring symptoms for 2 to 3 days to determine whether recovery occurs without antibiotic treatment. Many viral sinus infections improve spontaneously within this window, allowing patients to avoid unnecessary medication.

Distinguish between a lack of immediate symptom resolution and definite treatment failure. Sinus symptoms often persist for several days even after an antibiotic is started, and immediate relief is not expected. The IDSA guideline recommends reassessing a patient if symptoms worsen after 48 to 72 hours of initial empiric antibiotic treatment, or if they fail to improve after 3 to 5 days. This reassessment period is designed to catch early signs of treatment failure without subjecting patients to premature changes in therapy.

If a patient does not improve or gets worse during this window, the clinician should evaluate for resistant pathogens, a noninfectious cause, a structural abnormality, or an alternative diagnosis. This is not an automatic switch to a broader-spectrum antibiotic, as broader drugs are not always more effective and carry higher risks of side effects. Promising a specific recovery time is not possible, as individual healing rates vary. The focus is on careful monitoring and timely reassessment when the clinical course deviates from expectations.

Why unnecessary or inappropriate antibiotics can cause harm

Using antibiotics for viral sinus infections provides no clinical benefit, yet it exposes the patient to potential harm. Antibiotics do not treat viruses, so taking them for a viral infection only introduces the risk of adverse effects without improving the illness. Common side effects can include rash, gastrointestinal distress, and severe allergic reactions.

Beyond individual harm, unnecessary antibiotic use contributes to the broader public health crisis of antimicrobial resistance. When antibiotics are used without need, bacteria can develop resistance, making future infections harder to treat. Antibiotics can disrupt the normal gut flora, potentially leading to severe secondary infections such as Clostridioides difficile (C. difficile) infection.

Patients should never use leftover antibiotics, share prescriptions, or attempt to self-treat sinus infections by choosing a drug from an online list. Antibiotic selection requires professional assessment of the specific pathogen, patient history, and local resistance patterns. Attempting to self-prescribe or using outdated medications increases the risk of treatment failure and adverse events. Inappropriate antibiotic use also fails to address the underlying cause if the infection is viral or if a non-infectious condition, such as allergies, is mimicking sinusitis.

When to seek medical care

Because sinus symptoms can overlap between viral and bacterial causes, knowing when to seek professional evaluation is essential. The CDC advises contacting a healthcare professional for several specific reasons. These include severe headache or facial pain, which may indicate a more serious complication or different diagnosis. Symptoms that worsen after a period of initial improvement are another key trigger, as this pattern often suggests a secondary bacterial infection.

Symptoms that last more than 10 days without any improvement also warrant medical assessment. A fever lasting longer than 3 to 4 days, particularly if high-grade, should prompt evaluation. Patients who experience multiple sinus infections within a year should also seek care, as recurrent infections may require a different management approach, such as evaluation for underlying structural or immune issues.

These evaluation triggers do not automatically mean antibiotics are needed. They indicate that a clinician's assessment is necessary to determine the cause of the symptoms and the most appropriate treatment. Only a healthcare professional can distinguish between a self-limiting viral illness, a bacterial infection requiring antibiotics, or other conditions that mimic sinusitis. Seeking timely care ensures that treatment is aligned with the actual cause of the illness.